
How To Stand Out On LinkedIn And Own Your Industry In 2025
If I asked your LinkedIn connections what you did and what you believed, what would they say? Would they be able to recite your mission statement, define your dream client, and explain exactly how you help them achieve results? Most people on LinkedIn are invisible because no one knows what they stand for. They aren't consistent with their message. And that's a problem.
Someone with half your experience is building a bigger business because they have twice the clarity and triple the conviction. Don't get left behind. Don't feel the pain of missing out when you could be using LinkedIn to become successful beyond your wildest dreams.
They're not smarter than you. They're not more qualified. They just decided to choose a lane and stay in it. It's your turn.
Stop hiding: stand out on LinkedIn by choosing one message
Pick the hill you're willing to die on and plant your flag there. Every post, every comment, every interaction should reinforce this one core message. If your thing is "pricing psychology for SaaS founders," talk about nothing else for six months. When you define your swimlane, the right people start showing up. People begin tagging you in pricing discussions. Potential clients DM you before making their next move.
You don't need variety in yourLinkedIn posts. Your audience doesn't even need you to be interesting. They need you to be useful in one specific way. Think about the most successful thought leaders on LinkedIn. Gary Vaynerchuk talks about hustle. Brené Brown talks about vulnerability. Simon Sinek talks about finding your why. They've been saying the same thing for years, just finding new ways to package it. You get known by saying something real, then saying it again tomorrow.
Your energy shows up in every word you type. When you write from a place of desperation, trying to prove you belong, people can smell it through their screens. Compare "I've been thinking about customer retention strategies" with "Customer retention is broken. Here's what we're doing differently." One sounds like you're asking permission to speak. The other sounds like you're already in charge. Imposter syndrome has no place in your world.
Claim your authority without years of experience or fancy credentials. Speak with the confidence of someone who's already arrived. Position yourself as the expert rather than the student. What happens next: people start treating you like an expert. They share your posts with their teams. They screenshot your advice. They come to you with their biggest challenges because you sound like someone who's already solved them.
Nobody has time for your three-paragraph humble brag about closing a big deal. But a screenshot of that contract value with one powerful line makes people pay attention. Visual proof is worth more written claims. When you share your client's 400% revenue increase, don't write an essay. Show the graph and add a few words. Simple.
Your proof should be easy to scan and impossible to ignore. Screenshots of client testimonials, before-and-after metrics, calendar bookings, and revenue dashboards tell your story fast. The most engaging posts on LinkedIn include evidence. Show the Slack message where your client says you changed their business. Show the waitlist for your program. Show the DM from someone implementing your advice. Let your results do the talking.
Another month of LinkedIn posts are in the comments you left on other people's posts. That off-the-cuff response where you broke down your entire pricing philosophy becomes next week's viral post. The framework you sketched out to help someone struggling with team management is a carousel waiting to happen. Most of your best content is hidden in replies because that's where you (and everyone else) are most real.
Start treating every comment like potential content. When someone asks a great question, give them an answer worth stealing. Create a feedback loop of engagement. Then trawl through those conversations for insights, or paste them into ChatGPT and ask questions. Your audience is literally telling you what they want to know more about. Expand detailed responses into full posts and weekly series.
Your LinkedIn headline is so important and most people waste on job titles. "Marketing manager at generic company" tells me nothing about why I should care. But "I help busy mums get more sleep without taking pills"? Now they are listening. Your headline should make your ideal client think two things: "This person gets me" and "I need what they're offering."
Make it undeniable. Lead with your strongest belief about your industry. Call out exactly who you serve. Promise the transformation they're desperate for. Watch your inbound inquiries triple. Finally say what you mean, not what you think you're meant to say. Your headline should feel like a belief statement, not a business card.
Own your space on LinkedIn without apology
You don't need a huge audience to win on LinkedIn. You need clarity about what you stand for and the courage to say it repeatedly. Consistency over creativity, conviction over consensus. While everyone else is trying to go viral with motivational quotes, you'll be building an audience of buyers by solving one specific problem better than anyone else. Stand out by owning one thing, and owning it loudly. Pick your message, perfect your proof, and keep showing up.
Update your LinkedIn profile to attract ideal coaching and consultancy clients.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
20 minutes ago
- Yahoo
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio